Molecular architecture of native HIV-1 gp120 trimers.

Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science (2010) 10.69

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature (2011) 7.20

Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science (2013) 5.53

A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (2011) 5.44

Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science (2013) 4.61

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog (2013) 4.23

Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science (2009) 4.20

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature (2010) 3.96

Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc Natl Acad Sci U S A (2009) 3.92

Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity (2012) 3.77

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature (2014) 3.73

Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science (2012) 3.53

Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature (2014) 3.50

A Blueprint for HIV Vaccine Discovery. Cell Host Microbe (2012) 3.27

Tilt-pair analysis of images from a range of different specimens in single-particle electron cryomicroscopy. J Mol Biol (2011) 3.16

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol (2013) 3.11

Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog (2012) 3.07

Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc Natl Acad Sci U S A (2013) 2.96

HIV-1 and influenza antibodies: seeing antigens in new ways. Nat Immunol (2009) 2.80

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1. Proc Natl Acad Sci U S A (2010) 2.77

Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc Natl Acad Sci U S A (2012) 2.69

Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. PLoS Pathog (2013) 2.66

Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog (2010) 2.55

Structure and assembly of immature HIV. Proc Natl Acad Sci U S A (2009) 2.51

Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr Opin Immunol (2010) 2.47

Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity (2014) 2.42

Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity (2014) 2.38

Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A (2011) 2.38

Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell (2014) 2.36

Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer. Nat Struct Mol Biol (2012) 2.36

Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J Virol (2011) 2.34

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. Nature (2014) 2.33

The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A (2009) 2.30

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog (2009) 2.29

Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nat Rev Immunol (2010) 2.20

Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. Proc Natl Acad Sci U S A (2013) 2.10

Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer. Proc Natl Acad Sci U S A (2013) 2.05

Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science (2014) 2.05

HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol (2011) 2.01

Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. Cell Rep (2014) 2.01

Few and far between: how HIV may be evading antibody avidity. PLoS Pathog (2010) 1.94

Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. J Virol (2013) 1.93

Structural basis of respiratory syncytial virus neutralization by motavizumab. Nat Struct Mol Biol (2010) 1.89

Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J Virol (2010) 1.89

Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment. J Virol (2009) 1.88

Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy. Nat Struct Mol Biol (2013) 1.80

Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface. Proc Natl Acad Sci U S A (2009) 1.79

Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1. Proc Natl Acad Sci U S A (2013) 1.76

Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10. Proc Natl Acad Sci U S A (2009) 1.74

Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness. J Exp Med (2010) 1.74

Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathog (2011) 1.70

A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene. J Virol (2015) 1.66

Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat Struct Mol Biol (2015) 1.64

A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry. Nat Chem Biol (2014) 1.64

Molecular architecture of chemoreceptor arrays revealed by cryoelectron tomography of Escherichia coli minicells. Proc Natl Acad Sci U S A (2012) 1.63

Modern uses of electron microscopy for detection of viruses. Clin Microbiol Rev (2009) 1.63

Intact flagellar motor of Borrelia burgdorferi revealed by cryo-electron tomography: evidence for stator ring curvature and rotor/C-ring assembly flexion. J Bacteriol (2009) 1.61

Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog (2012) 1.61

Averaging of electron subtomograms and random conical tilt reconstructions through likelihood optimization. Structure (2009) 1.59

Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. Cold Spring Harb Perspect Med (2011) 1.58

The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions. J Virol (2008) 1.57

Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure. Proc Natl Acad Sci U S A (2010) 1.54

Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers. J Virol (2013) 1.54

Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells. PLoS Pathog (2015) 1.50

The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol (2012) 1.50

The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter. J Virol (2010) 1.49

HIV entry and envelope glycoprotein-mediated fusion. J Biol Chem (2012) 1.48

Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity. PLoS Pathog (2011) 1.47

Is assembly of the SNARE complex enough to fuel membrane fusion? J Biol Chem (2009) 1.46

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies. J Exp Med (2011) 1.46

Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer. PLoS One (2015) 1.46

High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site. Sci Transl Med (2012) 1.45

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV. J Transl Med (2011) 1.45

Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA. Immunol Rev (2012) 1.44

A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J Virol (2010) 1.43

Cryo electron tomography of native HIV-1 budding sites. PLoS Pathog (2010) 1.39

Structural comparison of HIV-1 envelope spikes with and without the V1/V2 loop. J Virol (2010) 1.39

Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein. J Virol (2013) 1.38

Membrane protein structure determination using cryo-electron tomography and 3D image averaging. Curr Opin Struct Biol (2009) 1.38

CD4-induced activation in a soluble HIV-1 Env trimer. Structure (2014) 1.38

Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine (2009) 1.37

Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer. Science (2016) 1.36

Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign. Proc Natl Acad Sci U S A (2014) 1.34

Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity. J Virol (2011) 1.30

Structural changes in Influenza virus at low pH characterized by cryo-electron tomography. J Virol (2012) 1.30

Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs. PLoS Pathog (2008) 1.29

Structure of trimeric HIV-1 envelope glycoproteins. Proc Natl Acad Sci U S A (2013) 1.29

Progress in the rational design of an AIDS vaccine. Philos Trans R Soc Lond B Biol Sci (2011) 1.28

Atomic resolution cryo electron microscopy of macromolecular complexes. Adv Protein Chem Struct Biol (2011) 1.27

Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat Chem Biol (2012) 1.27

A functional interaction between gp41 and gp120 is observed for monomeric but not oligomeric, uncleaved HIV-1 Env gp140. J Virol (2013) 1.25

In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1. J Virol (2010) 1.25

Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion. J Virol (2012) 1.24

Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged. J Virol (2010) 1.23

Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties. PLoS Pathog (2015) 1.23

Transitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domain. J Virol (2009) 1.23

Cellular architecture of Treponema pallidum: novel flagellum, periplasmic cone, and cell envelope as revealed by cryo electron tomography. J Mol Biol (2010) 1.22

Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120. J Virol (2012) 1.21

Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation. Biochemistry (2009) 1.20

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. Virology (2009) 1.20

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47

Computer visualization of three-dimensional image data using IMOD. J Struct Biol (1996) 25.42

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature (1998) 24.69

The antigenic structure of the HIV gp120 envelope glycoprotein. Nature (1998) 12.44

Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature (2007) 11.73

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature (2002) 9.62

HIV vaccine design and the neutralizing antibody problem. Nat Immunol (2004) 9.48

HIV entry and its inhibition. Cell (1998) 9.42

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med (1991) 9.28

Structure of an unliganded simian immunodeficiency virus gp120 core. Nature (2005) 8.30

Structure of a V3-containing HIV-1 gp120 core. Science (2005) 7.69

Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature (2006) 6.78

Visualizing density maps with UCSF Chimera. J Struct Biol (2006) 5.75

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol (1998) 5.05

Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A (2000) 4.44

Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J Virol (2005) 3.93

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol (2000) 3.52

Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J Virol (1997) 3.46

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med (1990) 3.01

Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathog (2006) 2.81

The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J Virol (2005) 2.35

Antibody-based HIV-1 vaccines: recent developments and future directions. PLoS Med (2007) 2.20

Classification and 3D averaging with missing wedge correction in biological electron tomography. J Struct Biol (2008) 2.19

Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. PLoS Pathog (2007) 2.14

A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope. J Virol (2002) 1.97

3D reconstruction and processing of volumetric data in cryo-electron tomography. J Struct Biol (2006) 1.96

Bridging the imaging gap: visualizing subcellular architecture with electron tomography. Curr Opin Microbiol (2005) 1.70

HIV-1 neutralization: mechanisms and relevance to vaccine design. Curr HIV Res (2007) 1.65

Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120. J Biol Chem (2007) 1.48

Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific. J Biol Chem (2007) 1.17

Reconstruction of the orientation distribution function in single- and multiple-shell q-ball imaging within constant solid angle. Magn Reson Med (2010) 3.24

Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog (2012) 3.07

Pushing spatial and temporal resolution for functional and diffusion MRI in the Human Connectome Project. Neuroimage (2013) 2.68

Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog (2010) 2.55

Direct visualization of Escherichia coli chemotaxis receptor arrays using cryo-electron microscopy. Proc Natl Acad Sci U S A (2007) 2.51

Advances in diffusion MRI acquisition and processing in the Human Connectome Project. Neuroimage (2013) 2.46

Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A (2011) 2.38

Sparse representation for color image restoration. IEEE Trans Image Process (2008) 2.17

Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. PLoS Pathog (2007) 2.14

Three-dimensional structure of a bacterial oxalate transporter. Nat Struct Biol (2002) 2.10

A Hough transform global probabilistic approach to multiple-subject diffusion MRI tractography. Med Image Anal (2011) 1.98

Site-specific 3D imaging of cells and tissues with a dual beam microscope. J Struct Biol (2006) 1.96

Electron microscopic analysis of membrane assemblies formed by the bacterial chemotaxis receptor Tsr. J Bacteriol (2003) 1.82

Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy. Nat Struct Mol Biol (2013) 1.80

Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog (2009) 1.70

Automated image acquisition and processing using a new generation of 4K x 4K CCD cameras for cryo electron microscopic studies of macromolecular assemblies. J Struct Biol (2003) 1.67

3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A (2010) 1.52

Cryo-electron tomography of bacteria: progress, challenges and future prospects. Nat Rev Microbiol (2009) 1.51

Chemoreceptors in Caulobacter crescentus: trimers of receptor dimers in a partially ordered hexagonally packed array. J Bacteriol (2008) 1.50

Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120. J Biol Chem (2007) 1.48

Three-dimensional electron microscopic imaging of membrane invaginations in Escherichia coli overproducing the chemotaxis receptor Tsr. J Bacteriol (2004) 1.45

The development of gyrification in childhood and adolescence. Brain Cogn (2009) 1.43

Role of HAMP domains in chemotaxis signaling by bacterial chemoreceptors. Proc Natl Acad Sci U S A (2008) 1.40

Membrane protein structure determination using cryo-electron tomography and 3D image averaging. Curr Opin Struct Biol (2009) 1.38

Structural model for 12-helix transporters belonging to the major facilitator superfamily. J Bacteriol (2003) 1.38

Comprehensive in vivo mapping of the human basal ganglia and thalamic connectome in individuals using 7T MRI. PLoS One (2012) 1.36

A core-weighted fitting method for docking atomic structures into low-resolution maps: application to cryo-electron microscopy. J Struct Biol (2003) 1.36

Protein secondary structure determination by constrained single-particle cryo-electron tomography. Structure (2012) 1.36

Correlative 3D imaging of whole mammalian cells with light and electron microscopy. J Struct Biol (2011) 1.33

3D imaging of mammalian cells with ion-abrasion scanning electron microscopy. J Struct Biol (2008) 1.31

Molecular architecture and mechanism of an icosahedral pyruvate dehydrogenase complex: a multifunctional catalytic machine. EMBO J (2002) 1.30

Cell surface filaments of the gliding bacterium Flavobacterium johnsoniae revealed by cryo-electron tomography. J Bacteriol (2007) 1.30

3D imaging of diatoms with ion-abrasion scanning electron microscopy. J Struct Biol (2009) 1.28

Solving inverse problems with piecewise linear estimators: from Gaussian mixture models to structured sparsity. IEEE Trans Image Process (2011) 1.25

An energy-based three-dimensional segmentation approach for the quantitative interpretation of electron tomograms. IEEE Trans Image Process (2005) 1.20

Data management challenges in three-dimensional EM. Nat Struct Mol Biol (2012) 1.19

A geometric method for automatic extraction of sulcal fundi. IEEE Trans Med Imaging (2007) 1.19

HIV-1 envelope glycoprotein structure. Curr Opin Struct Biol (2013) 1.19

Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol (2011) 1.18

Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain. Proc Natl Acad Sci U S A (2013) 1.17

Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A (2013) 1.17

Is image steganography natural? IEEE Trans Image Process (2005) 1.17

Magnetic resonance field strength effects on diffusion measures and brain connectivity networks. Brain Connect (2013) 1.16

Learning to sense sparse signals: simultaneous sensing matrix and sparsifying dictionary optimization. IEEE Trans Image Process (2009) 1.15

Three-dimensional imaging of the highly bent architecture of Bdellovibrio bacteriovorus by using cryo-electron tomography. J Bacteriol (2008) 1.14

Topological analysis of population activity in visual cortex. J Vis (2008) 1.14

Measurement of cortical thickness from MRI by minimum line integrals on soft-classified tissue. Hum Brain Mapp (2009) 1.13

Coded aperture compressive temporal imaging. Opt Express (2013) 1.13

Hierarchical topological network analysis of anatomical human brain connectivity and differences related to sex and kinship. Neuroimage (2011) 1.12

Design of multishell sampling schemes with uniform coverage in diffusion MRI. Magn Reson Med (2013) 1.12

Electron tomography of viruses. Curr Opin Struct Biol (2007) 1.10

Statistical analysis of RNA backbone. IEEE/ACM Trans Comput Biol Bioinform (2006) 1.09

Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. J Struct Biol (2005) 1.08

Stoichiometry and absolute quantification of proteins with mass spectrometry using fluorescent and isotope-labeled concatenated peptide standards. Mol Cell Proteomics (2007) 1.08

Implicit brain imaging. Neuroimage (2004) 1.07

Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives. Proc Natl Acad Sci U S A (2012) 1.06

Automated 100-position specimen loader and image acquisition system for transmission electron microscopy. J Struct Biol (2006) 1.05

Cryo-electron microscopy--a primer for the non-microscopist. FEBS J (2012) 1.04

Chemotaxis kinase CheA is activated by three neighbouring chemoreceptor dimers as effectively as by receptor clusters. Mol Microbiol (2010) 1.02

The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions. Neuroimage (2013) 1.01

HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. Blood (2011) 1.01

Electron tomography in nanoparticle imaging and analysis. Nanomedicine (Lond) (2008) 1.00

Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance. AAPS J (2014) 0.99

Lateral density of receptor arrays in the membrane plane influences sensitivity of the E. coli chemotaxis response. EMBO J (2011) 0.99

Multiple Q-shell ODF reconstruction in Q-ball imaging. Med Image Comput Comput Assist Interv (2009) 0.99

Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification scheme. J Org Chem (2006) 0.98

Structure and transport mechanism of the bacterial oxalate transporter OxlT. Biophys J (2004) 0.98

Protein conformational changes in the bacteriorhodopsin photocycle: comparison of findings from electron and X-ray crystallographic analyses. PLoS One (2009) 0.98

Computational separation of conformational heterogeneity using cryo-electron tomography and 3D sub-volume averaging. J Struct Biol (2012) 0.98

Simultaneous structure and texture image inpainting. IEEE Trans Image Process (2003) 0.97

Molecular structure of a 9-MDa icosahedral pyruvate dehydrogenase subcomplex containing the E2 and E3 enzymes using cryoelectron microscopy. J Biol Chem (2005) 0.96

A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography. J Struct Biol (2012) 0.95

Structural snapshots of conformational changes in a seven-helix membrane protein: lessons from bacteriorhodopsin. Curr Opin Struct Biol (2009) 0.95